SCHEMBL4378374

SCHEMBL4378374

CC(N)c1ccc(N(C)C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
TSHR P16473 4/20 0.55
ALOX15 P16050 2/20 0.55
HSD17B10 Q99714 1/20 0.55
ADRB2 P07550 1/20 0.52
CYP3A4 P08684 3/20 0.50
MAPK1 P28482 3/20 0.50
TDP1 Q9NUW8 3/20 0.50
TP53 P04637 1/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
SLC2A1 P11166 1/20 0.47
GAA P10253 3/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
CYP1A2 P05177 1/20 0.42
MAPT P10636 1/20 0.42
PHLPP2 Q6ZVD8 1/20 0.42
PDE2A O00408 1/20 0.42
ADRA2A P08913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19033895 0.93 SLC2A1 (0.57) ALDH1A1TSHRALOX15HSD17B10ADRB2
SCHEMBL30913857 0.93 MAPT (0.48) ALDH1A1TSHRALOX15HSD17B10ADRB2
SCHEMBL2137996 0.82 ALDH1A1 (0.58) ALDH1A1TSHRALOX15HSD17B10CYP3A4
SCHEMBL1304701 0.82 ALDH1A1 (0.58) ALDH1A1TSHRALOX15HSD17B10CYP3A4
SCHEMBL2136374 0.82 ALDH1A1 (0.58) ALDH1A1TSHRALOX15HSD17B10CYP3A4
SCHEMBL10349155 0.82 ALDH1A1 (0.58) ALDH1A1TSHRALOX15HSD17B10CYP3A4
SCHEMBL1314596 0.81 ADRB2 (0.72) ALDH1A1TSHRALOX15HSD17B10ADRB2
Hydrochloric Acid SCHEMBL21837184 0.80 ALDH1A1 (0.55) ALDH1A1TSHRALOX15HSD17B10CYP3A4
SCHEMBL3893552 0.79 ALDH1A1 (0.61) ALDH1A1TSHRALOX15HSD17B10CYP3A4
SCHEMBL346292 0.79 ALDH1A1 (0.61) ALDH1A1TSHRALOX15HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269719-A Urea derivatives as CB1 allosteric modulators RTI国际 2022-04-01 CN disclosed
EP-3483149-B1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME YUHAN CORP (KR) 2021-01-13 EP disclosed
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same YUHAN CORPORATION (KR) 2019-08-20 US disclosed
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same YUHAN CORPORATION (KR) 2019-05-16 US disclosed
EP-3483149-A1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Yuhan Corporation (KR) 2019-05-15 EP disclosed
WO-2009012375-A2 SQUARATE KINASE INHIBITORS WYETH (US) 2009-01-22 WO disclosed
US-20030036653-A1 Diaminopyridine-containing thiourea inhibitors of herpes viruses AMERICAN HOME PRODUCTS CORPORATION 2003-02-20 US disclosed
US-20020026055-A1 Aminopyridine-containing thiourea inhibitors of herpes viruses AMERICAN HOME PRODUCTS CORPORATION 2002-02-28 US disclosed
US-20010039348-A1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group AMERICAN HOME PRODUCTS CORPORATION (US) 2001-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same ILK, SBDS, BDKRB1 ALDH1A1 3073/4885TSHR 991/4885ALOX15 3284/4885
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same ILK, SBDS, BDKRB1 ALDH1A1 3073/4885TSHR 991/4885ALOX15 3284/4885
US-20030036653-A1 Diaminopyridine-containing thiourea inhibitors of herpes viruses HAVCR2, CCR6, CXCR6 ALDH1A1 3447/4885TSHR 60/4885ALOX15 4832/4885
US-20010039348-A1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group CCR6, HAVCR2, BCOR ALDH1A1 3620/4885TSHR 174/4885ALOX15 4695/4885
US-20020026055-A1 Aminopyridine-containing thiourea inhibitors of herpes viruses TK1, TPMT, CXCR6 ALDH1A1 3601/4885TSHR 881/4885ALOX15 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.